These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28302371)

  • 1. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
    McMahon GM; Hwang SJ; Clish CB; Tin A; Yang Q; Larson MG; Rhee EP; Li M; ; Levy D; O'Donnell CJ; Coresh J; Young JH; Gerszten RE; Fox CS
    Kidney Int; 2017 Jun; 91(6):1426-1435. PubMed ID: 28302371
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Luo S; Surapaneni A; Zheng Z; Rhee EP; Coresh J; Hung AM; Nadkarni GN; Yu B; Boerwinkle E; Tin A; Arking DE; Steinbrenner I; Schlosser P; Köttgen A; Grams ME
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):37-47. PubMed ID: 33380473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk score and risk of stage 3 chronic kidney disease.
    Ma J; Yang Q; Hwang SJ; Fox CS; Chu AY
    BMC Nephrol; 2017 Jan; 18(1):32. PubMed ID: 28103844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between frailty, genetic predisposition, and chronic kidney disease risk in middle-aged and older adults: A prospective cohort study.
    Yang H; Li Z; Zhang Y; Chang Q; Jiang J; Liu Y; Ji C; Chen L; Xia Y; Zhao Y
    Maturitas; 2024 Sep; 187():108059. PubMed ID: 38941958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.
    Da Silva Lodge M; Pullen N; Pereira M; Johnson TS
    PLoS One; 2022; 17(1):e0262104. PubMed ID: 35041708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin-to-leptin ratio and incident chronic kidney disease: Sex and body composition-dependent association.
    Park HS; Park SH; Seong Y; Kim HJ; Choi HY; Rhee Y; Park HC; Jhee JH
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1298-1308. PubMed ID: 38632706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a genetic risk score for CKD stage 3 in the general population.
    O'Seaghdha CM; Yang Q; Wu H; Hwang SJ; Fox CS
    Am J Kidney Dis; 2012 Jan; 59(1):19-24. PubMed ID: 21995970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease.
    He WJ; Chen J; Razavi AC; Hu EA; Grams ME; Yu B; Parikh CR; Boerwinkle E; Bazzano L; Qi L; Kelly TN; Coresh J; Rebholz CM
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1620-1629. PubMed ID: 34737201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts.
    Ong KL; Marklund M; Huang L; Rye KA; Hui N; Pan XF; Rebholz CM; Kim H; Steffen LM; van Westing AC; Geleijnse JM; Hoogeveen EK; Chen YY; Chien KL; Fretts AM; Lemaitre RN; Imamura F; Forouhi NG; Wareham NJ; Birukov A; Jäger S; Kuxhaus O; Schulze MB; de Mello VD; Tuomilehto J; Uusitupa M; Lindström J; Tintle N; Harris WS; Yamasaki K; Hirakawa Y; Ninomiya T; Tanaka T; Ferrucci L; Bandinelli S; Virtanen JK; Voutilainen A; Jayasena T; Thalamuthu A; Poljak A; Bustamante S; Sachdev PS; Senn MK; Rich SS; Tsai MY; Wood AC; Laakso M; Lankinen M; Yang X; Sun L; Li H; Lin X; Nowak C; Ärnlöv J; Risérus U; Lind L; Le Goff M; Samieri C; Helmer C; Qian F; Micha R; Tin A; Köttgen A; de Boer IH; Siscovick DS; Mozaffarian D; Wu JH
    BMJ; 2023 Jan; 380():e072909. PubMed ID: 36653033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers improve the prediction of prevalent and incident severe chronic kidney disease.
    Nusinovici S; Li H; Chong C; Yu M; Sørensen IMH; Bisgaard LS; Christoffersen C; Bro S; Liu S; Liu JJ; Chi LS; Wong TY; Tan GSW; Cheng CY; Sabanayagam C
    J Nephrol; 2024 May; 37(4):1007-1016. PubMed ID: 38308753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.
    Gupta J; Mitra N; Townsend RR; Fischer M; Schelling JR; Margolis DJ
    Wound Repair Regen; 2016 Jul; 24(4):705-11. PubMed ID: 27237708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort.
    Couch CA; Ament Z; Patki A; Kijpaisalratana N; Bhave V; Jones AC; Armstrong ND; Cushman M; Kimberly WT; Irvin MR
    J Am Heart Assoc; 2024 May; 13(9):e032643. PubMed ID: 38686877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.
    Hattori Y; Naito M; Satoh M; Nakatochi M; Naito H; Kato M; Takagi S; Matsunaga T; Seiki T; Sasakabe T; Suma S; Kawai S; Okada R; Hishida A; Hamajima N; Wakai K
    Toxicol Sci; 2016 Jul; 152(1):181-93. PubMed ID: 27122239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite Genome-Wide Association Study for Indoleamine 2,3-Dioxygenase Activity Associated with Chronic Kidney Disease.
    Kim HR; Jin HS; Eom YB
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional gastrointestinal disorders, mental health, genetic susceptibility, and incident chronic kidney disease.
    Liu M; He P; Ye Z; Yang S; Zhang Y; Wu Q; Zhou C; Zhang Y; Hou FF; Qin X
    Chin Med J (Engl); 2024 May; 137(9):1088-1094. PubMed ID: 37668042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease.
    Crocco P; Dato S; La Grotta R; Passarino G; Rose G
    BMC Med Genomics; 2024 Jun; 17(1):163. PubMed ID: 38890684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined epidemiologic and metabolomic approach improves CKD prediction.
    Rhee EP; Clish CB; Ghorbani A; Larson MG; Elmariah S; McCabe E; Yang Q; Cheng S; Pierce K; Deik A; Souza AL; Farrell L; Domos C; Yeh RW; Palacios I; Rosenfield K; Vasan RS; Florez JC; Wang TJ; Fox CS; Gerszten RE
    J Am Soc Nephrol; 2013 Jul; 24(8):1330-8. PubMed ID: 23687356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uromodulin levels associate with a common UMOD variant and risk for incident CKD.
    Köttgen A; Hwang SJ; Larson MG; Van Eyk JE; Fu Q; Benjamin EJ; Dehghan A; Glazer NL; Kao WH; Harris TB; Gudnason V; Shlipak MG; Yang Q; Coresh J; Levy D; Fox CS
    J Am Soc Nephrol; 2010 Feb; 21(2):337-44. PubMed ID: 19959715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low lung function and the risk of incident chronic kidney disease in the Malmö Preventive Project cohort.
    Zaigham S; Christensson A; Wollmer P; Engström G
    BMC Nephrol; 2020 Apr; 21(1):124. PubMed ID: 32268898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis.
    Weon B; Jang Y; Jo J; Jin W; Ha S; Ko A; Oh YK; Lim CS; Lee JP; Won S; Lee J
    PLoS One; 2024; 19(4):e0299605. PubMed ID: 38626061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.